New anti-tuberculosis drugs with novel mechanisms of action

QR Code

New anti-tuberculosis drugs with novel mechanisms of action

Bibliographic Details
Main Authors:	Rivers, E., Mancera, Ricardo
Format:	Journal Article
Published:	Bentham Science Publishers 2008
Online Access:	http://hdl.handle.net/20.500.11937/20094

Similar Items

New anti-tuberculosis drugs in clinical trials with novel mechanisms of action
by: Rivers, E., et al.
Published: (2008)

Antimicrobial peptides as an alternative to anti-tuberculosis drugs
by: Almatar, Manaf, et al.
Published: (2018)

Adverse drug reactions of anti tuberculosis drugs among tuberculosis patients treated in Hospital Sg. Buloh / Nurniza Nisbar
by: Nisbar, Nurniza
Published: (2016)

Rational inhibitor design, synthesis and evaluation as steps towards the discovery of new anti-tuberculosis drugs
by: Macnab, Elinor
Published: (2025)

Molecular modeling of hydration in drug design
by: Mancera, Ricardo
Published: (2007)

Adverse effects of anti-tuberculosis drugs on HepG2 cell bioenergetics
by: Elmorsy, E., et al.
Published: (2016)

Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia
by: Omar, Ahmad Marzuki, et al.
Published: (2008)

Novel anti-tuberculosis nanodelivery formulation of ethambutol with graphene oxide
by: Bullo, Saifullah, et al.
Published: (2017)

Novel Psychoactive Substances 14Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs
by: Hassan, Zurina, et al.
Published: (2017)

A novel para-amino salicylic acid magnesium layered hydroxide nanocomposite anti-tuberculosis drug delivery system with enhanced in vitro therapeutic and anti-inflammatory properties
by: Saifullah, Bullo, et al.
Published: (2021)

Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets
by: Alsayed, S.S.R., et al.
Published: (2023)

Heparin/heparan sulphate-based drugs
by: Gandhi, Neha, et al.
Published: (2010)

Acute drug reaction and non-compliance to anti-tuberculosis medications: a case study
by: Mahmud, Aidalina, et al.
Published: (2014)

Development of nanodelivery systems for anti-tuberculosis drugs using metal hydroxides nanolayered hosts
by: Saifullah
Published: (2014)

Studies On The Activity Of Isoniazid Derivatives And Their Combinations With Other Anti-TB Drugs On Mycobacterium Tuberculosis
by: Parumasivam, Thaigarajan
Published: (2012)

Mechanism of action of antiplatelet drugs on decompression sickness in rats: A protective effect of anti-GPIIbIIIa therapy
by: Lambrechts, K., et al.
Published: (2015)

New milestone for anti-hiv drug
by: The Star
Published: (2016)

Developing drugs from sugars: current state of glycosaminoglycan-derived therapeutics
by: Gandhi, Neha, et al.
Published: (2012)

Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent
by: Trivedi, Vijay Laxmi, et al.
Published: (2023)

Anti-cancer actions in commonly used drugs: epidemiology led by laboratory science
by: Walker, Alex J.
Published: (2011)

Explorative Study Of Adverse Drug Reactions And Drug-Resistant Tuberculosis Among Tuberculosis Patients In Hospital Pulau Pinang, Malaysia
by: Kurniawati, Fivy
Published: (2013)

Novel functionalized polymers for nanoparticle formulations with anti cancer drugs
by: Puri, Sanyogitta
Published: (2007)

Elucidating the mechanism of action of novel lactams on Pseudomonas aeruginosa
by: Pantalone, P.
Published: (2019)

Agomelatine in Depressive Disorders: Its Novel Mechanisms of Action
by: Srinivasan, Venkataramanujan, et al.
Published: (2012)

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
by: Tacar, O., et al.
Published: (2013)

Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis
by: Alsayed, S.S.R., et al.
Published: (2021)

Thiosemicarbazone Iron Chelator: Evaluation of the anti-cancer activity and mechanisms of action
by: Yu, W., et al.
Published: (2011)

Sustained release formulation of an anti-tuberculosis drug based on para-amino salicylic acid-zinc layered hydroxide nanocomposite
by: Saifullah, Bullo, et al.
Published: (2013)

Discovery of Mycobacterium tuberculosis CYP121 new inhibitor via structure-based drug repurposing
by: El Moudaka, Tarek, et al.
Published: (2022)

Preliminary Structure-Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains
by: Onajole, O., et al.
Published: (2013)

Extensively drug-resistant tuberculosis in a young child
by: Bhagavathula, Akshaya Srikanth, et al.
Published: (2016)

Indoleamides are active against drug-resistant Mycobacterium tuberculosis
by: Lun, S., et al.
Published: (2013)

Molecular mechanism of the synergistic effects of vitrification solutions on the stability of phospholipid bilayers
by: Hughes, Z., et al.
Published: (2014)

Impact of nitric oxide synthase 2 gene variant on risk of anti-tuberculosis drug- induced liver injury in the Malaysian population
by: Vishala Sivapalan,, et al.
Published: (2020)

A New Method for Estimating the Importance of Hydrophobic Groups in the Binding Site of a Protein
by: Kelly, M., et al.
Published: (2005)

The Role of Polymerase Chain Reaction (PCR) in Diagnosis of Spine Tuberculosis after Pre-operative Anti-tuberculosis Treatment
by: Ahmad Hata, Rasit, et al.
Published: (2011)

Anti-allodynic and antihyperalgesic properties of zerumbone and their mechanisms of action in mice model of neuropathic pain
by: Gopalsamy, Banulata
Published: (2017)

ABC transporters and G protein-coupled receptors: perspectives for novel anti-cancer drugs
by: Adamska, Aleksandra
Published: (2019)

Molecular mechanism of solvent cryoprotection in aqueous DMSO solutions
by: Mandumpal, Jestin, et al.
Published: (2011)

Examining the role of protein structural dynamics in drug resistance in Mycobacterium tuberculosis
by: Shaw, Daniel, et al.
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lllotjotblhgofstogbauc5ib7